论文部分内容阅读
近年来由于新型抗癌药物不断涌现,不论在基础研究、还是临床应用均有很大进展。本文就有关膀胱癌的化学治疗进展略加综述。膀胱癌约占90%为移行细胞癌。临床上将肿瘤仅浸润膀胱粘膜的为浅表性膀胱癌;浸润膀胱肌层及周围淋巴结的为浸润性膀胱癌;具有远处如肺、骨、肝等转移的为转移性膀胱癌。同样,化学治疗的方法也归纳为三种。对浅表性膀胱癌主要用于 TUR 手术后化学药物及膀胱内灌注;对浸润性膀胱癌主要作为手术前后
In recent years, due to the continuous emergence of new anti-cancer drugs, both in basic research, or clinical applications have made great progress. This article gives a brief overview of the progress of chemotherapy for bladder cancer. About 90% of bladder cancer is transitional cell carcinoma. Clinically invasive tumor of the bladder mucosa only for the superficial bladder cancer; infiltration of the bladder muscle and surrounding lymph nodes for invasive bladder cancer; with distant metastasis, such as lung, bone, liver and other metastatic bladder cancer. Similarly, the methods of chemotherapy are also grouped into three types. For superficial bladder cancer is mainly used for chemical drugs and intravesical instillation after TUR surgery; invasive bladder cancer mainly as a preoperative